“
the heterogeneity of the disease is suggested by diverse clinical manifestations such as mild or severe preeclampsia, early onset (<34 weeks) or late onset (>34 weeks) of the disease and presence or absence of intra-uterine growth restriction (IUGR) with preeclampsia (Dekker and Sibai, 2001
”
”